Intra-Cellular Therapies Price to Sales Ratio 2013-2022 | ITCI
Historical PS ratio values for Intra-Cellular Therapies (ITCI) over the last 10 years. The current P/S ratio for Intra-Cellular Therapies as of July 01, 2022 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Intra-Cellular Therapies P/S Ratio Historical Data |
Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
2022-07-01 |
55.17 |
|
45.46 |
2022-03-31 |
61.19 |
$1.21 |
50.42 |
2021-12-31 |
52.34 |
$1.03 |
50.72 |
2021-09-30 |
37.28 |
$0.89 |
41.75 |
2021-06-30 |
40.82 |
$0.73 |
56.23 |
2021-03-31 |
33.93 |
$0.51 |
66.81 |
2020-12-31 |
31.80 |
$0.33 |
96.86 |
2020-09-30 |
25.66 |
$0.15 |
169.57 |
2020-06-30 |
25.67 |
$0.05 |
566.12 |
2020-03-31 |
15.37 |
$0.02 |
923.56 |
2019-12-31 |
34.31 |
0 |
0.00 |
2019-09-30 |
7.47 |
0 |
0.00 |
2019-06-30 |
12.98 |
0 |
0.00 |
2019-03-31 |
12.18 |
0 |
0.00 |
2018-12-31 |
11.39 |
0 |
0.00 |
2018-09-30 |
21.70 |
$0.00 |
0.00 |
2018-06-30 |
17.67 |
$0.00 |
0.00 |
2018-03-31 |
21.05 |
$0.00 |
0.00 |
2017-12-31 |
14.48 |
$0.01 |
0.00 |
2017-09-30 |
15.78 |
$0.01 |
0.00 |
2017-06-30 |
12.42 |
$0.01 |
0.00 |
2017-03-31 |
16.25 |
$0.01 |
0.00 |
2016-12-31 |
15.09 |
$0.01 |
0.00 |
2016-09-30 |
15.24 |
$0.01 |
0.00 |
2016-06-30 |
38.82 |
$0.01 |
0.00 |
2016-03-31 |
27.80 |
$0.00 |
0.00 |
2015-12-31 |
53.79 |
$0.00 |
0.00 |
2015-09-30 |
40.04 |
$0.00 |
0.00 |
2015-06-30 |
31.95 |
$0.01 |
0.00 |
2015-03-31 |
23.88 |
$0.01 |
1690.04 |
2014-12-31 |
17.65 |
$0.02 |
866.88 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$5.204B |
$0.084B |
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
|